Some Valeant Creditors Reportedly 'Balking' At Revised Lending Agreement; Investors Concerned
April 04, 2016 at 17:07 PM EDT
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares finished a down Monday with a sharp move to the $26 mark after a Bloomberg report ...
